Literature DB >> 34306920

Visual Outcomes after Endoscopic Endonasal Transsphenoidal Resection of Pituitary Adenomas: Our Institutional Experience.

Max J van Essen1, Ivo S Muskens1,2, Nayan Lamba3, Stephan F J Belunek4, Arthur T J van der Boog5, G Johan Amelink1, Peter H Gosselaar1, Tristan P C van Doormaal1, Aline M E Stades6, Joost J C Verhoeff7, Maria M van Genderen4, Christine A E Eenhorst4, Marike L D Broekman3,8,9.   

Abstract

Objectives  Visual dysfunction in patients with pituitary adenomas is a clear indication for endoscopic endonasal transsphenoidal surgery (EETS). However, the visual outcomes vary greatly among patients and it remains unclear what tumor, patient, and surgical characteristics contribute to postoperative visual outcomes. Methods  One hundred patients with pituitary adenomas who underwent EETS between January 2011 and June 2015 in a single institution were retrospectively reviewed. General patient characteristics, pre- and postoperative visual status, clinical presentation, tumor characteristics, hormone production, radiological features, and procedural characteristics were evaluated for association with presenting visual signs and visual outcomes postoperatively. Suprasellar tumor extension (SSE) was graded 0 to 4 following a grading system as formulated by Fujimoto et al. Results  Sixty-six (66/100) of all patients showed visual field defects (VFD) at the time of surgery, of whom 18% (12/66) were asymptomatic. VFD improved in 35 (35%) patients and worsened in 4 (4%) patients postoperatively. Mean visual acuity (VA) improved from 0.67 preoperatively to 0.84 postoperatively ( p  = 0.04). Nonfunctioning pituitary adenomas (NFPAs) and Fujimoto grade were independent predictors of preoperative VFD in the entire cohort ( p  = 0.02 and p  < 0.01 respectively). A higher grade of SSE was the only factor independently associated with postoperative improvement of VFD ( p  = 0.03). NFPA and Fujimoto grade 3 were independent predictors of VA improvement (both p  = 0.04). Conclusion  EETS significantly improved both VA and VFD for most patients, although a few patients showed deterioration of visual deficits postoperatively. Higher degrees of SSE and NFPA were independent predictors of favorable visual outcomes. Thieme. All rights reserved.

Entities:  

Keywords:  endoscopy; pituitary adenoma; transsphenoidal; visual acuity; visual field; visual outcome

Year:  2020        PMID: 34306920      PMCID: PMC8289550          DOI: 10.1055/s-0039-3402020

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  39 in total

Review 1.  Recovery of vision following transsphenoidal surgery for pituitary adenomas.

Authors:  M Powell
Journal:  Br J Neurosurg       Date:  1995       Impact factor: 1.596

2.  Pituitary tumor surgery: review of 3004 cases.

Authors:  Mauro Loyo-Varela; Tenoch Herrada-Pineda; Francisco Revilla-Pacheco; Salvador Manrique-Guzman
Journal:  World Neurosurg       Date:  2012-06-23       Impact factor: 2.104

3.  Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma.

Authors:  Hasan A Zaidi; Al-Wala Awad; Michael A Bohl; Kristina Chapple; Laura Knecht; Heidi Jahnke; William L White; Andrew S Little
Journal:  J Neurosurg       Date:  2015-10-16       Impact factor: 5.115

4.  Transsphenoidal decompression of the optic nerve and chiasm. Visual results in 62 patients.

Authors:  E R Laws; J C Trautmann; R W Hollenhorst
Journal:  J Neurosurg       Date:  1977-06       Impact factor: 5.115

5.  Single-surgeon fully endoscopic endonasal transsphenoidal surgery: outcomes in three-hundred consecutive cases.

Authors:  Adam N Mamelak; John Carmichael; Vivien H Bonert; Odelia Cooper; Shlomo Melmed
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

6.  Demographic differences in incidence for pituitary adenoma.

Authors:  Bradley D McDowell; Robert B Wallace; Ryan M Carnahan; Elizabeth A Chrischilles; Charles F Lynch; Janet A Schlechte
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

7.  Results of transsphenoidal surgery in a large series of patients with pituitary adenoma.

Authors:  Pietro Mortini; Marco Losa; Raffaella Barzaghi; Nicola Boari; Massimo Giovanelli
Journal:  Neurosurgery       Date:  2005-06       Impact factor: 4.654

8.  Endoscopic endonasal transsphenoidal removal of recurrent and regrowing pituitary adenomas: experience on a 59-patient series.

Authors:  Luigi M Cavallo; Domenico Solari; Anastasia Tasiou; Felice Esposito; Michelangelo de Angelis; Alfonso Iodice D'Enza; Paolo Cappabianca
Journal:  World Neurosurg       Date:  2012-10-06       Impact factor: 2.104

9.  Recovery of vision following treatment of pituitary tumours; application of a new system of assessment to patients treated by transsphenoidal operation.

Authors:  G Findlay; R M McFadzean; G Teasdale
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

10.  Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.

Authors:  In Ho Lee; Neil R Miller; Elcin Zan; Fabiana Tavares; Ari M Blitz; Heejong Sung; David M Yousem; Michael V Boland
Journal:  AJR Am J Roentgenol       Date:  2015-11       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.